A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis
Conditions: NSCLC Interventions: Drug: combination of Trilaciclib and Pemetrexed Sponsors: Jiangsu Province Nanjing Brain Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Brain | Chemotherapy | Hospitals | Neurology | Non-Small Cell Lung Cancer | Research | Study